Vigil Neuroscience, Inc.
NASDAQ:VIGL
3.6 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Assets: | ||||
| Current Assets: | ||||
| Cash & Cash Equivalents
| 51.992 | 186.605 | 91.42 | 24.151 |
| Short Term Investments
| 65.948 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 117.94 | 186.605 | 91.42 | 24.151 |
| Net Receivables
| 1.485 | 0.015 | 0 | 0 |
| Inventory
| 0 | 10.557 | 0 | 0 |
| Other Current Assets
| 2.482 | 0.628 | 0.466 | 0.07 |
| Total Current Assets
| 121.907 | 197.805 | 97.483 | 25.296 |
| Non-Current Assets: | ||||
| Property, Plant & Equipment, Net
| 17.941 | 1.395 | 1.274 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0.927 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.01 | 0.266 | 3.684 | 0 |
| Total Non-Current Assets
| 18.951 | 2.588 | 4.958 | 0 |
| Total Assets
| 140.858 | 200.393 | 102.441 | 25.296 |
| Liabilities & Equity: | ||||
| Current Liabilities: | ||||
| Account Payables
| 1.946 | 1.942 | 3.977 | 1.107 |
| Short Term Debt
| 0.905 | 0.176 | 0.873 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 4.915 | 0 |
| Other Current Liabilities
| 6.864 | 7.252 | -3.861 | -0.219 |
| Total Current Liabilities
| 11.661 | 11.312 | 9.881 | 1.995 |
| Non-Current Liabilities: | ||||
| Long Term Debt
| 12.945 | 0.153 | 0.064 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 1.965 | 161.939 | 51.584 |
| Total Non-Current Liabilities
| 12.945 | 2.118 | 162.003 | 51.584 |
| Total Liabilities
| 24.606 | 11.312 | 171.884 | 53.579 |
| Equity: | ||||
| Preferred Stock
| 0 | 200.393 | 72.327 | 47.034 |
| Common Stock
| 0.004 | 0.004 | 0 | 0 |
| Retained Earnings
| -222.772 | -140.134 | -71.829 | -28.546 |
| Accumulated Other Comprehensive Income/Loss
| -0.005 | -0 | 0 | -0 |
| Other Total Stockholders Equity
| 339.025 | 128.818 | -69.941 | -46.771 |
| Total Shareholders Equity
| 116.252 | 189.081 | -69.443 | -28.283 |
| Total Equity
| 116.252 | 189.081 | -69.443 | -28.283 |
| Total Liabilities & Shareholders Equity
| 140.858 | 200.393 | 102.441 | 25.296 |